Abstract
The aim of the present study was to characterize the prejunctional modulation of evoked release of endogenous noradrenaline in rabbit vas deferens by the use of muscarinic receptor agonists and subtype-prefering antagonists.
Vasa deferentia of the rabbit were stimulated electrically by trains of 120 pulses delivered at 4 Hz or trains of 30 pulses at 1 Hz. The inhibition by muscarinic agonists of the stimulation-evoked overflow of endogenous noradrenaline in the absence and presence of antagonists was used to determine affinity constants for antagonists. These values were compared with those observed at putative M1 receptors inhibiting neurogenic twitch contractions in the rabbit vas deferens and with affinity data obtained at M1(m1)-M4(m5) receptors in functional studies and binding experiments.
The evoked overflow of noradrenaline from sympathetic nerves was enhanced by the Al receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), the P2 purinoceptor antagonist pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS) and indomethacin, indicating a tonic inhibition by endogenous A1 and P2 purinoceptor agonists and prostanoids, respectively. The stimulation-evoked overflow at 4 Hz was not sensitive to inhibition by the muscarinic agonists methacholine or 4-(4-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium iodide (4-Cl-McN-A-343). In contrast, at a stimulation frequency of 1 Hz the evoked noradrenaline release was decreased by muscarinic agonists (EC50): arecaidine propargyl ester (0.062 μM), 4-Cl-McN-A-343 (0.32 μM), 4-(4-fluorophenylcarbamoyloxy)-2-butynylN-methyl-pyrrolidinium tosylate (4-F-PyMcN+; 0.48 μM) and methacholine (0.86 μM). The affinity constants of most of the muscarinic antagonists [atropine: pKB = 9.47; (R)-trihexyphenidyl: pKB = 9.18; pirenzepine: pA2 = 7.68; methoctramine: pKB = 6.90] are consistent with estimates of these antagonists at M1(m1) receptors determined in various functional and binding studies. The high antagonistic potency of pirenzepine and (R)-trihexyphenidyl and the agonistic activity of 4-F-PyMcN+ argue for the involvement of M1, and against that of M2 and M3 receptors in the inhibition of evoked noradrenaline overflow. However, the high apparent pKB of 8.30 for himbacine is not in accordance with an M1 receptor; by contrast, it would be compatible with the presence of M2 or M4 receptors. The potencies of the tested muscarinic agonists and antagonists largely agree with those obtained for the inhibition of neurogenic twitch responses (0.05 Hz) in the rabbit vas deferens. In conclusion, the rabbit vas deferens is endowed with prejunctional muscarinic receptors mediating heteroinhibition of noradrenaline release that are probably of the same subtype as the putative M1 receptors inhibiting neurogenic twitch contractions, and are not of the M2, M3 or m5 subtype.
Similar content being viewed by others
References
Boddeke HWGM, Buttini M (1991) Pharmacological properties of cloned muscarinic receptors expressed in A9 L cells; comparison with in vitro models. Eur J Pharmacol 202:151–157
Bognar IT, Baumann B, Dammann F, Knoll B, Meincke M, Pallas S, Fuder H (1989) M2 muscarinic receptors on the iris sphincter muscle differ from those on the iris noradrenergic nerves. Eur J Pharmacol 163:263–274
Bognar IT, Altes U, Beinhauer C, Kessler I, Fuder H (1992) A muscarinic receptor different from the M1, M2, M3 and M4 subtypes mediates the contraction of the rabbit iris sphincter. Naunyn-Schmiedeberg's Arch Pharmacol 345:611–618
Bolden C, Cusack B, Richelson E (1992) Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in chinese hamster ovary cells. J Pharmacol Exp Ther 260:576–580
Burnstock G (1990) Co-transmission. Arch int Pharmacodyn 304:7–33
Caulfield MP, Brown DA (1991) Pharmacology of the putative M4 muscarinic receptor mediating Ca-current inhibition in neuroblastoma × glioma hybrid (NG 108–15) cells. Br J Pharmacol 104:39–44
Darroch SA, Choo LK, Mitchelson F (1992) Prejunctional muscarine receptors in the rabbit ear artery differ from M1, M2 and M3 muscarine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 345:288–295
Dörje F, Friebe T, Tacke R, Mutschler E, Lambrecht G (1990) Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus. Naunyn-Schmiedeberg's Arch Pharmacol 342:284–289
Dörje F, Levey AI, Brann MR (1991a) Immunological detection of muscarinic receptor subtype proteins (m1–m5) in rabbit peripheral tissues. Mol Pharmacol 40:459–462
Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR (1991b) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256:727–733
Duckles SP, Budai D (1990) Stimulation intensity as critical determinant of presynaptic receptor effectiveness. Trends Pharmacol Sci 11:440–443
Eltze M (1988) Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur J Pharmacol 151:205–221
Eltze M, Gmelin G, Wess J, Strohmann C, Tacke R, Mutschler E, Lambrecht G (1988) Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type. Eur J Pharmacol 158:233–242
Eltze M, Ullrich B, Mutschler E, Moser U, Bungardt E, Friebe T, Gubitz C, Tacke R, Lambrecht G (1993) Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney. Eur J Pharmacol 238:343–355
Field JL, Newberry NR (1989) Methoctramine and hexahydrodifenidol antagonise two muscarinic responses on the rat superior cervical ganglion with opposite selectivity. Neurosci Lett 100:254–258
Flynn DD, Vaishnav AA, Mash DC (1992) Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. Mol Pharmacol 41:736–742
Fuder H, Meiser C, Wormstall H, Muscholl E (1981) The effects of several muscarinic antagonists on pre- and postsynaptic receptors in the isolated rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 316:31–37
Fuder H, Rink D, Muscholl E (1982) Sympathetic nerve stimulation on the perfused rat heart: affinities of N-methylatropine and pirenzepine at pre- and postsynaptic muscarine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 318:210–219
Fuder H, Schöpf H, Unckell J, Wesner MT, Melchiorre C, Tacke R, Mutschler E, Lambrecht G (1989) Different muscarine receptors mediate the prejunctional inhibition of [3H]-noradrenaline release in rat or guinea-pig iris and the contraction of the rabbit iris sphincter muscle. Naunyn-Schmiedeberg's Arch Pharmacol 340:597–604
Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Handb Exp Pharmacol, vol 33. Catecholamines. Springer, Berlin Heidelberg New York, pp 283–335
Grimm U (1992) Muscarinic and purinergic inhibition of noradrenaline release evoked by field stimulation of rabbit isolated vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 345 [Suppl]: R 100 (abstract)
Grimm U, Fuder H, Mutschler E, Lambrecht G (1993) Muscarinic inhibition of noradrenaline release evoked by field stimulation on rabbit isolated vas deferens. Life Sci 52:563 (abstract)
Habermeier-Muth A, Altes U, Forsyth KM, Muscholl E (1990) A presynaptic excitatory Ml muscarine receptor at postganglionic cardiac noradrenergic nerve fibres that is activated by endogenous acetylcholine. Naunyn-Schmiedeberg's Arch Pharmacol 342: 483–489
Halbrügge T, Ungell A-L, Wölfel R, Graefe K-H (1988) Total body, systemic and pulmonary clearance and fractional extraction of unlabelled and differently 3H-labelled noradrenaline in the anaesthetized rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 338:361–367
Haleen SJ, Steffen RP, Hamilton HW (1987) PD 116, 948, a highly selective A1 adenosine receptor antagonist. Life Sci 40:555–561
Hughes J (1972) Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br J Pharmacol 44:472–491
Kasakov L, Ellis J, Kirkpatrick K, Milner P, Burnstock G (1988) Direct evidence for concomitant release of noradrenaline, adenosine 5′-triphosphate and neuropeptide Y from sympathetic nerve supplying the guinea-pig vas deferens. J Anton Nerv Syst 22:75–82
Kilbinger H (1977) Modulation by oxotremorine and atropine of acetylcholine release evoked by electrical stimulation of the myenteric plexus of the guinea-pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 300:145–151
Kilbinger H, Nafziger M (1985) Two types of neuronal muscarine receptors modulating acetylcholine release from guinea-pig myenteric plexus. Naunyn-Schmiedeberg's Arch Pharmacol 328:304–309
Kilbinger H, Halim S, Lambrecht G, Weiler W, Wessler I (1984) Comparison of affinities of muscarinic antagonists to pre- and postjunctional receptors in the guinea-pig ileum. Eur J Pharmacol 103: 313–320
Kirkpatrick KA, Burnstock G (1992) Evidence that the inhibition of ATP release from sympathetic nerves by adenosine is a physiological mechanism. Gen Pharmac 23:1045–1050
von Kügelgen I, Starke K (1991) Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol Sci 12:301–324
von Kugelgen I, Bültmann R, Starke K (1989) Effects of suramin and α,β-methylene ATP indicate noradrenaline-ATP co-transmission in the response of the mouse vas deferens to single and low frequency pulses. Naunyn-Schmiedeberg's Arch Pharmacol 340:760–763
Lambrecht G, Feifel R, Moser U, Aasen AJ, Waelbroeck M, Christophe J, Mutschler E (1988) Stereoselectivity of the enantiomers of trihexyphenidyl and its methiodide at muscarinic receptor subtypes. Eur J Pharmacol 155:167–170
Lambrecht G, Friebe T, Grimm U, Windscheif U, Bungardt E, Hildebrandt C, Baumert HG, Spatz-Kumbel G, Mutschler E (1992) PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. Eur J Pharmacol 217:217–219
Lambrecht G, Moser U, Grimm U, Pfaff O, Hermanni U, Hildebrandt C, Waelbroeck M, Christophe J, Mutschler E (1993) New functionally selective muscarinic agonists. Life Sci 52:481–488
Lattimer N, Rhodes KF (1985) A difference in the affinity of some selective α2-adrenoceptor antagonists when compared on isolated vasa deferentia of rat and rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 329:278–281
McKinney M, Anderson D, Forray C, El-Fakahany EE (1989) Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor. J Pharmacol Exp Ther 250:565–572
Miller JH, Aagaard PJ, Gibson VA, McKinney M (1992) Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors. J Pharmacol Exp Ther 263:663–667
Muscholl E (1980) Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am J Physiol 239:H713-H720
Palacios JM, Bolliger G, Closse A, Enz A, Gmelin G, Malanowski J (1986) The pharmacological assessment of RS 86 (2-ethyl-8-methyl2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist. Eur J Pharmacol 125:45–62
Racké K, Hey C, Wessler I (1992) Endogenous noradrenaline release from guinea-pig isolated trachea is inhibited by activation of M2 receptors. Br J Pharmacol 107:3–4
Sagrada A, Duranti P, Giudici L, Schiavone A (1993) Himbacine discriminates between two M1 receptor-mediated responses. Life Sci 52:574 (abstract)
Sarges R, Howard HR, Browne RG, Lebel LA, Seymour PA, Koe BK (1990) 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. J Med Chem 33:2240–2254
Saye J, Binder SB, TrachteGJ, Peach MJ (1986) Angiotensin peptides and prostaglandin E2 synthesis: modulation of neurogenic responses in the rabbit vas deferens. Endocrinology 119:1895–1903
Sharkey J, Ritz MC, Schenden JA, Hanson RC, Kuhar MJ (1988) Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol Exp Ther 246:1048–1052
Sneddon P, Westfall DP, Colby J, Fedan IS (1984) A pharmacological investigation of the biphasic nature of the contractile response of rabbit and rat vas deferens to field stimulation. Life Sci 35:1903–1912
Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124
Stjärne L (1975) Pre- and post-junctional receptor-mediated cholinergic interactions with adrenergic transmission in guinea-pig vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 288:305–310
Tallarida RJ, Murray RB (1986) Manual of pharmacologic calculations with computer programs. Springer, Berlin Heidelberg New York Tokyo
Todorov L, Windisch K, Shersen H, Lajtha A, Papasova M, Vizi ES (1991) Prejunctional nicotinic receptors involved in facilitation of stimulation-evoked noradrenaline release from the vas deferens of the guinea-pig. Br J Pharmacol 102:186–190
Trachte GJ (1990) Pharmacological differentiation of angiotensin effects in the rabbit isolated vas deferens with dithiothreitol and pertussis toxin. J Pharmacol Exp Ther 253:80–84
Trachte GJ, Binder SB, Peach MJ (1989) Indirect evidence for separate vesicular neuronal origins of norepinephrine and ATP in the rabbit vas deferens. Eur J Pharmacol 164:425–433
Waelbroeck M, Tastenoy M, Camus J, Christophe J (1990) Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol Pharmacol 38:267–273
Waelbroeck M, Camus J, Tastenoy M, Mutschler E, Strohmann C, Tacke R, Schjelderup L, Aasen AJ, Lambrecht G, Christophe J (1992) Stereoselective interaction of procyclidine, hexahydrodifenidol, hexbutinol and oxyphencyclimine, and of related antagonists, with four muscarinic receptors. Eur J Pharmacol - Mol Pharmacol Sect 227:33–42
Westfall TC (1977) Local regulation of adrenergic neurotransmission. Physiol Rev 57:659–728
Windscheif U, Lambrecht G, Grimm U, Hildebrandt C, Spatz-Kumbel G, Baumert HG, Mutschler E (1992) Characterization of P1-puri-noceptors in rabbit vas deferens. Int J Purine Pyrimidine Res 3:113 (abstract)
Ziganshin AU, Hoyle CHV, Bo X, Lambrecht G, Mutschler E, Bäumert HG, Burnstock G (1993) PPADS selectively antagonizes P2x-purinoceptor-mediated responses in the rabbit urinary bladder. Br J Pharmacol (in press)
Author information
Authors and Affiliations
Additional information
Correspondence to: U. Grimm at the above address
Rights and permissions
About this article
Cite this article
Grimm, U., Fuder, H., Moser, U. et al. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 349, 1–10 (1994). https://doi.org/10.1007/BF00178199
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00178199